Universal Health Services Inc (UHS.N) has reached a significant milestone by hitting a 52-week high in its stock price. This achievement reflects the company's strong performance and investor confidence in its future prospects.
Despite the broader market trading sideways with mixed signals, UHS's upward movement stands out. The stock's increase of 3.10% indicates a positive sentiment among investors, likely driven by the company's operational strengths and strategic initiatives.
As major benchmarks are tracking around +0.61% for the session, UHS's performance suggests that specific factors related to the company are influencing its stock price more than the overall market trends.
Investors will be keen to see if UHS can maintain this momentum and what future developments may arise that could further impact its stock performance.
Wall Street analysts forecast UHS stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for UHS is 248.00 USD with a low forecast of 190.00 USD and a high forecast of 302.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
15 Analyst Rating
Wall Street analysts forecast UHS stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for UHS is 248.00 USD with a low forecast of 190.00 USD and a high forecast of 302.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
7 Buy
7 Hold
1 Sell
Moderate Buy
Current: 203.020
Low
190.00
Averages
248.00
High
302.00
Current: 203.020
Low
190.00
Averages
248.00
High
302.00
Barclays
NULL -> Overweight
maintain
$263 -> $262
2026-01-22
Reason
Barclays
Price Target
$263 -> $262
AI Analysis
2026-01-22
maintain
NULL -> Overweight
Reason
Barclays lowered the firm's price target on Universal Health to $262 from $263 and keeps an Overweight rating on the shares. The firm adjusted targets in the healthcare facilities and managed care group as part of a preview of 2026 outlooks.
TD Cowen
Buy
maintain
$251 -> $245
2026-01-07
Reason
TD Cowen
Price Target
$251 -> $245
2026-01-07
maintain
Buy
Reason
TD Cowen lowered the firm's price target on Universal Health to $245 from $251 and keeps a Buy rating on the shares. The firm updated its model as they now see a slim chance of an ACA subsidy extension and are now contemplating associated payor mix headwinds.
Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for UHS
Unlock Now
Wells Fargo
Overweight -> Equal Weight
downgrade
$235
2026-01-07
Reason
Wells Fargo
Price Target
$235
2026-01-07
downgrade
Overweight -> Equal Weight
Reason
Wells Fargo downgraded Universal Health to Equal Weight from Overweight with a $235 price target.
Wells Fargo
Overweight
to
Equal Weight
downgrade
$259 -> $235
2026-01-07
Reason
Wells Fargo
Price Target
$259 -> $235
2026-01-07
downgrade
Overweight
to
Equal Weight
Reason
As previously reported, Wells Fargo downgraded Universal Health to Equal Weight from Overweight with a price target of $235, down from $259. For managed care organizations, the firm is most constructive on Medicare Advantage with uncertainty high for Medicaid/Exchanges. Wells sees a more difficult backdrop for hospitals in 2026 as post-COVID tailwinds wane and legislative risks near. Distributor debate remains revisions vs. multiples.
About UHS
Universal Health Services, Inc. is a holding company. The Company operates, through its subsidiaries, including its management company. It is engaged in owning and operating acute care hospitals and outpatient facilities, and behavioral healthcare facilities. Its segments include acute care hospital services, behavioral health care services, and Other. It owns and operates approximately 359 inpatient facilities, and 60 outpatient and other facilities located in 39 states, Washington, D.C., the United Kingdom, and Puerto Rico. It provides services, which include general and specialty surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic care, coronary care, pediatric services, pharmacy services and/or behavioral health services. It also provides capital resources, as well as a variety of management services to its facilities, including information services, finance and control systems, physician recruitment services, and public relations.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
